SMC
AERI

S. Muoio & Co’s Aerie Pharmaceuticals AERI Stock Holding History

S. Muoio & Co’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$555K Buy
+36,655
New +$426K 0.73% 45

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

S. Muoio & Co's AERI Position: Q3 2022 in Review

S. Muoio & Co opened a new position in Aerie Pharmaceuticals (AERI) in Q3 2022: 36,655 shares worth $555K. The stake represents 0.73% of the portfolio and ranks #45 among its holdings.

156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • S. Muoio & Co held 36,655 shares of Aerie Pharmaceuticals worth $555K as of Q3 2022.
  • Aerie Pharmaceuticals was a new S. Muoio & Co position in Q3 2022.
  • Aerie Pharmaceuticals made up 0.73% of S. Muoio & Co's portfolio in Q3 2022, its #45 holding.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on S. Muoio & Co's 13F filing for Q3 2022, filed 14 Nov 2022.